Table 1 Baseline characteristics of participants categorized by enrollment site of the Swedish CArdioPulmonary bioImage study (SCAPIS) cohort.
Enrollment site | |||
---|---|---|---|
Malmö (N = 4,911) | Uppsala (N = 4,717) | N | |
Age, years* | 57.4 (4.3) | 57.7 (4.4) | 9,628 |
Female, n (%) | 2,619 (53.3%) | 2,422 (51.3%) | 9,628 |
Country of birth, n (%) | 9,590 | ||
Scandinavia | 3,849 (78.7%) | 4,233 (90.0%) | |
Europe | 670 (13.7%) | 183 (3.9%) | |
Asia | 257 (5.3%) | 189 (4.0%) | |
Other area | 112 (2.3%) | 97 (2.1%) | |
Smoking status, n(%) | 9,628 | ||
Never smoker | 2,089 (42.5%) | 2,612 (55.4%) | |
Former smoker | 1,852 (37.7%) | 1,445 (30.6%) | |
Current smoker | 846 (17.2%) | 421 (8.9%) | |
Diabetes Mellitus, n(%) | 242 (5.1%) | 197 (4.4%) | 9,179 |
Body mass index* | 27.3 (4.58) | 27.0 (4.35) | 9,628 |
Systolic blood pressure (mmHg)* | 122 (16) | 125 (16) | 9,619 |
Diastolic blood pressure (mmHg)* | 75 (10) | 77 (10) | 9,617 |
Plasma Glucose level (mg/dl)* | 101 (23.3) | 103 (18.2) | 9,624 |
Albumin creatinine ratio (ug/mg)† | 8.62 [3.32;21.2] | 2.91 [1.12;10.7] | 9,424 |
KIM-1/Cr (ng/mg)† | - | 0.71 [0.33;1.28] | 4,652 |
Osteopontin/Cr (pg/mg)† | 828,852 [529,830;1172,904] | 817,184 [526,880;1180,364] | 9,541 |
DKK-3/Cr (pg/mg)† | 415 [225;789] | 475 [264;908] | 9,541 |
EGF/Cr (pg/mg)† | - | 20,290 [15,280;27,748] | 4,654 |
Anti-hyperlipidemia treatment, n (%) | 403 (8.6%) | 348 (7.8%) | 9,171 |
Anti-diabetes treatment, n (%) | 206 (4.4%) | 159 (3.6%) | 9,169 |
CCTA: | 9,187 | ||
Group 1 (no stenosis) | 2,780 (58.2%) | 2,638 (59.8%) | |
Group 2 (< 50% stenosis) | 1,653 (34.6%) | 1,433 (32.5%) | |
Group 3 ( > = 50% stenosis) | 341 (7.1%) | 342 (7.8%) | |
Coronary artery calcium score (CACS) group, n (%) | 9,272 | ||
Group 1 (= 0) | 2,666 (56.1%) | 2,806 (62.1%) | |
Group 2 (0.1–100) | 1,424 (30.0%) | 1,216 (26.9%) | |
Group 3 (101–400) | 437 (9.2%) | 337 (7.5%) | |
Group 4 (> 401) | 225 (4.7%) | 161 (3.6%) |